Rocky Mountain Cancer Centers (Midtown)
Denver, CO
Filters
Save & Share
Clear Filters
Diagnosis
Treatment History
Accepting patients
Teclistamab
A Study of Outpatient Administration of Teclistamab, a BCMA-targeting Bispecific Antibody, in Multiple Myeloma Patients
Learn more- Bispecific Antibody
- BCMA
- Phase 2
Accepting patients
Early Detection Blood Tests
Blinded Reference Set for Multicancer Early Detection Blood Tests
Learn more- Observational Trial
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsAccepting patients
DRAMMATIC
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC)
Learn more- Monoclonal Antibody
- CD38
- Maintenance
- Phase 3
Accepting patients
Selinexor
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Learn more- SINE
- Phase 2